13G Filing: JPMorgan Chase & Co and Kite Pharma Inc. (KITE)

Page 2 of 3 – SEC Filing

CUSIP
No. 
49803L109    
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
JPMORGAN CHASE & CO
13-62624428
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)

(a)
o
(b)
o
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES
BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH:
5 SOLE VOTING POWER
1,184,466
6 SHARED VOTING POWER
0
7 SOLE DISPOSITIVE POWER
1,214,765
8 SHARED DISPOSITIVE POWER
0
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
1,215,790
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
o
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.1%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
HC

FOOTNOTES

Follow Kite Pharma Inc. (NASDAQ:KITE)